Human sulfatase transiently and functionally active expressed in E. coli K12 [PDF]
The recombinant human iduronate 2-sulfate sulfatase (hrIDS) was transiently and functionally active expressed in E. coli K12. The enzyme activity (crude extract) at 100 ml and 400 ml oscillated between 0.25 and 10.58 nmol h-1 mg-1.
Niño, Adriana Vanegas +6 more
core
HUNTER SYNDROME : REPORT OF A SEVERE AND A MILD CASE
Hunter syndrome is one of several types of mucopolysaccharidosis and is inherited in an X-linked recessive manner. Severity of Hunter syndrome is distinguished by the degree of intellectual impairment and prognosis.
大久保, 芳明 +5 more
core +1 more source
La maladie de Hunter, ou Mucopolysaccharidose de type II (MPSII) est une maladie lysosomale récessive liée à l'X due au déficit en iduronate sulfatase (IDS).
CUDRY, Stéphane, MAIRE, Irène
core
Identification of Multiple Sulfatase Deficiency (MSD) in newborn screening: A case study. [PDF]
Donti TR +4 more
europepmc +1 more source
Revealing the role of a novel <i>IDS</i> gene mutation in mucpolysaccharidosis type II: insights from computational analysis. [PDF]
Huang S +6 more
europepmc +1 more source
Human sulfatase transiently and functionally active expressed in E. coli K12
The recombinant human iduronate 2-sulfate sulfatase (hrIDS) was transiently and functionally active expressed in E. coli K12. The enzyme activity (crude extract) at 100 ml and 400 ml oscillated between 0.25 and 10.58 nmol h-1 mg-1.
Poutou Piñales, Raúl A. +6 more
core
A Contemporary Pathomechanistic Nosology of Inherited Lysosomal Disorders. [PDF]
McCarron EP +7 more
europepmc +1 more source
Subtle cellular phenotypes inform pathological and benign genetic mutants in the Iduronate-2 sulfatase gene. [PDF]
Viswanathan A +8 more
europepmc +1 more source
Introduction and hypothesis: Iduronate-2-sulfatase (IDS) is a lysosomal enzyme responsible for the removal of the 2-sulfate group from dermatan and heparan sulfate.
ARGENTON, FRANCESCO +6 more
core
A North Carolina newborn screening pilot for mucopolysaccharidosis II: Evaluating endogenous nonreducing end glycosaminoglycan analysis and IDS sequencing as higher-tier testing options. [PDF]
Kucera KS +17 more
europepmc +1 more source

